Topic Listing for Micrus Endovascular

Ability Protect Intellectual Property Proprietary Technology Through Patents Able Increase Penetration Markets Otherwise Compete Effectively
Abstentions Broker Non-vote Voting Acceleration Agreements
Accepted Market Access Products
Accounting Firm Accretion Redeemable Convertible Preferred Stock Redemption Value
Accruals Accrued Payments
Accumulated Other Comprehensive Income Loss Achieve Profitability
Adequate Supply Materials Harm Business Administrator Discretion
Administrator8221 Adoption Statement Financial Accounting Standard 123r Changes Existing
Advertising Costs Affect Conduct Business Reported Results Operations
Affiliate8221 Aggregated Option Exercises Last Year-end Values
Allowance Doubtful Accounts Amendment
Amendment Termination Amendments
Annual Grant Annual Meeting Stockholders
Anti-dilutive Securities Applicable Law8221
Appointment Distributor Approval Representations
Arbitration Assignment
Assignment Transfer Boston Scientific Assignment Transfer Micrus
Audit Committee Report Authority
Authority Board Committee Available Information
Available-for-sale Securities Award
Awardee8221 Bankruptcy
Base Salary Because Significant Stock Ownership Executive Officers Directors Principal
Become Involved Securities Class Action Litigation Divert Managements Become Subject Product Liability Claims Require Pay Damages
Benchmarking Compensation Beneficial Conversion Feature
Beneficial Ownership Reporting Compliance Biotronik
Biotronik Collaboration Board Discretion
Bsc License Micrus Business Experience Nominees Incumbent Directors
Calif 2008 8211 Micrus Endovascular Corporation Calif 2009 8211 Micrus Endovascular Corporation
Cash Awards Cash Awards Stock
Cash Equivalents Cash Equivalents Short-term Investments
Cash-based Incentive Compensation Cashless Exercise Procedure
Certain Confidential Information Contained Document Marked Brackets Been Certain Significant Risks Uncertainties
Cessation Date Change Control
Change Control Severance Arrangements Change Control8221
Changes Capital Structure Changes Existing Accounting Pronouncements Taxation Rules Practices Affect
Chemence Collaboration Choose Acquire New Complementary Businesses Products Technologies Instead
Civil Code California Clearance
Combinations Acquired Commitments Contingencies
Committee Common Stock
Common Stock Warrants Comparison Cumulative Total Return
Comparison Cumulative Total Return Among Micrus Endovascular Corporation Compensation Chief Executive Officer
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Committee Report Executive
Compensation Directors Competition
Compliance Laws Composition
Comprehensive Loss Concentration Credit Risk
Confidentiality Consent Independent Registered Public Accounting Firm
Consultant8221 Consulting Employment Relationship
Continuing Directors Continuing Fda Regulation
Continuing Jurisdiction Contractual Obligations
Contribution Control Event
Conversion Corporate Decisions
Corporate Governance Corporate Transaction
Corporate Transactions Corporation
Cost Goods Sold Counterparts
Covenant Not Sue Acquirer Covenant Not Sue Micrus
Critical Accounting Policies Estimates Customer Sales Reporting
Cut-back Preserve Benefits Damages Exceed Insurance Coverage
Death Disability Deductibility Executive Compensation
Defenses Preserved Defined Contribution Plans
Departure Directors Principal Officers Election Appointment Dependent Senior Management Team Key Clinical Advisors Scientific
Dependent Single Source Suppliers Components Materials Used Devices Director Independence
Director8221 Disclaimer
Dismissal Litigation Disposition Cardiac Peripheral Catheter Platform Assets
Dissolution Distributor
Distributor Obligations Distributor Qualifications
Dividend Policy Documents Incorporated Reference
Domestic Relations Order Earn-out Payment
Earthquakes Other Natural Disasters Effective Date
Election Directors Eligible Individuals
Employee Stock Purchase Plan Employee8221
Employees Employment Severance Agreements
Enforcement Entire Agreement
Entry Material Definitive Agreement Environmental
Equity Compensation Plan Information Equity Incentive Plan
Escrow Stock Certificates Established Market
Estimates Exact Name Registrant Specified Charter
Executive Compensation Philosophy Executive8221
Exercise Sars Exercise Vesting Options
Expiration Date8221 Fail Increase Direct Sales Force Timely Manner Business
Fail Properly Manage Anticipated Growth Business Suffer Failure Commercialize Obtain Marketing Authorizations
Failure Make Payment Fair Value Financial Instruments
Fair Value Measurements Fcpa Investigation
Fdas Premarket Clearance Approval Requirements Fees
Fees Paid Pricewaterhousecoopers Llp Field
Final Approval Release Regents Finances Personnel
Financial Disclosure Financial Restatements Accounting Policies
Fluctuate Significantly Future Periods Force Majeure
Foreign Currency Transactions Form 10-k
Form Payment Formation Business
Forward-looking Statements Future Capital Needs Uncertain Need Raise Additional Funds
Future Sales Common Stock Depress Price Future Such Funds Not Available Acceptable Terms
General General Administrative
General Compensation Policy Genesis
Genesis Collaboration Goodwill
Goodwill Intangible Assets Governing Law
Grant Date8221 Grant Dates
Grant Plan-based Awards Last Gross Profit
Headings Highly Competitive Market Segment Face Competition Large Well-established
Householding Proxy Materials Impairment Long-lived Assets
Implied License Incentive Stock Option8221
Income Taxes Incur Increased Costs Result Recently Enacted Proposed Changes
Indemnification Indemnification Distributor
Indemnification Micrus Index Consolidated Financial Statements
Industry Overview Initial Grant
Inspection Dispute Resolution Relating Satisfaction Product Specifications Intended Customers Not Achieve Expected Results
International International Operations Relationships Physicians Other Consultants Require Comply
Interventionalists Unable Obtain Sufficient Reimbursement Procedures Performed Products Inventories
Issuer Purchases Equity Securities Joint Venture
Lease Commitments Leaves Absence
Legal Expenses Liability Termination
License Licenses Personal
Limitation Liability Limitation Liability Indemnification Matters
Limitation License Limited Operating History Incurred Significant Losses Since Inception
Liquidity Liquidity Capital Resources
Listed Stock Litigation
Long-term Incentive Compensation Management8217s Attention Harm Business
Manufacture Products Delayed Manufacturing
Market Opportunity Marketing Authorizations
Marketing Distribution Rights Marketing Obligations
Marketing Plans Mediation Future Disputes
Medical Device Industry Characterized Patent Litigation Costly Result Meetings
Meetings Committees Board Directors Membership Power Act
Merit Method Payment
Methods Voting Microcoil Delivery System Deployment Mechanism
Microcoil Products Micrus
Micrus Endovascular Corporation Micrus License Bsc
Micrus Obligations Micrus Solution
Micrus Strategy Modifications Marketed Products Require New 510 Clearances Pre-market
Monitoring Monthly Reports
Mutual Covenants Not Sue Net Loss Per Share
Neurointerventionalists Unable Obtain Sufficient Reimbursement Procedures Performed Products Nominees
Nominees Board Directors Non Compliance
Non-compliance Non-employee Director8221
Non-employee Options Nonassignability Options
Nonassignability Sars Nonassignability Stock Awards
Nonstatutory Option8221 Not Able Develop New Products Product Enhancements Accepted
Not Intend Pay Cash Dividends Notice
Notices Notwithstanding Anything Else Agreement Otherwise Event Shall Micrus
Now Therefore Objectively Determinable Performance Condition
Off-balance Sheet Arrangements Officer8221
Operations Currently Conducted Several Locations Risk Earthquakes Other Option Exercises Stock Vested
Option Grants 2006 Option Price8221
Option Shares8221 Option Term
Options Sars Other Business
Other Elements Compensation Perquisites Other Income Net
Other Matters Other Non-current Liabilities
Outside Consultants Outstanding Equity Awards Year-end
Overview Ownership
Pacific Time Part
Pass-through Payment Obligations Patent Litigation
Patents Other Means Uncertain Patents Proprietary Rights
Pay Damages Pay Mix
Payment Pending Orders
Percent Stockholder Periods Prior Adoption Sfas 123r
Personnel Loss Them Harm Business Pharos Balloon-expandable Stent
Physician Advisors Plan8221
Policies Approval Related Transactions Policy Audit Committees Pre-approval Permissible Non-audit Services Independent
Potential Payments Termination Change Control Powers Attorney
Preferred Stock Preferred Stock Warrants
Premarket Approval Price
Price Common Stock Fluctuated Expect Continue Fluctuate Substantially Prices
Principles Consolidation Prior Plans
Procedure Proceeds
Product Liability Insurance Products
Products Alternative Other Available Products Development
Products Until Clearances Obtained Property Equipment
Proposal Prosecution Maintenance Patents
Protection Legends Provision Data
Proxy Solicitation Costs Publication Voting Results
Publicity Purchase Estimates
Purchase Price8221 Purpose
Purpose Proxy Statement Card Quarterly Operating Financial Results Gross Margins Likely Fluctuate
Quorum Requirement Recent Accounting Pronouncements
Recent Developments Redemption
Registrants Telephone Number Including Area Code Regulations
Rejection Product Related Stockholder Matters
Relationship Parties Releases
Report Independent Registered Public Accounting Firm Report Submitted Audit Committee Board Directors Micrus Endovascular
Reporting Representations Warranties Each Party
Repricings Required Evaluate Internal Control Over Financial Reporting 404
Research Development Resolution Disputes Relating Product Specifications
Responsibilities Return Product After Rejection Period
Return Property Revasc
Revasc Acquisition Revenue Recognition Product Warranty
Revenues Reverse Engineering
Review Management Independent Registered Public Accounting Firm Revoking Proxy
Right Repurchase Risks Costs Harm Business
Role Executives Compensation Decisions Sale Conveys Right Manufacture Copy
Sales International Markets Subject Foreign Currency Exchange Other Sales Marketing
Sar8221 8220stock Appreciation Right8221 Savings Plan
Schedule Schedule 11-a
Schedule 11-b Schedule Valuation Qualifying Accounts
Scope Discretion Seasonality
Securities Authorized Issuance Equity Compensation Plans Securities Litigation
Severability Share8221
Shipping Handling Products Signature
Signatures Source Shares
Stock Award8221 Stock Option Plan
Stock Option Plans Stock Options
Stock Ownership Guidelines Stock Performance Graph
Stock Plan Stock Quoted Securities Dealer
Stock-based Compensation Stockholder Approval
Stockholder Proposals 2007 Annual Meeting Stockholder Proposals 2008 Annual Meeting
Subject Damages Resulting Claims Employees Wrongfully Used Disclosed Subsidiaries Micrus Endovascular Corporation
Substitute Award8221 Substitute Option8221
Substitute Options Substitute Sar8221
Substitute Sars Substitute Stock Award
Substitute Stock Award8221 Successfully Integrate Them Cost Effective Non-disruptive Manner
Successfully Integrate Them Cost-effective Non-disruptive Manner Suffer
Summary Compensation Table Suppliers Fail Comply Fdas Quality System Regulations Manufacture
Survival Rights Table Contents
Target Pay Positioning Taxes
Term Termination Not Sole Remedy
Termination Service Termination8221
Terms Conditions Terms Distributor Requirements
Terms Purchase Orders Territory
Third-party Beneficiaries Third-party Reimbursement
Title Traceability
Trademark Transactions Management Others
Unable Effectively Manage Inventory Held Consignment Intended Customers United States
Unregistered Securities Sold 2007 Unresolved Staff Comments
Value Date Vascon
Vascular Vesting
Vote Important Vote Required
Votes Required Proposals Voting Confidentiality
Voting Procedures Waiver
Warranty Warranty Legal Representation
Webcast Annual Meeting Whereas
Widely Used Witness Whereof
Wrongfully Used Disclosed Alleged Trade Secrets Former Employers 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki